Back to User profile » Dr Bruce Parsons
Papers published by Dr Bruce Parsons:
Integrating Machine Learning With Microsimulation to Classify Hypothetical, Novel Patients for Predicting Pregabalin Treatment Response Based on Observational and Randomized Data in Patients With Painful Diabetic Peripheral Neuropathy
Alexander Jr J, Edwards RA, Manca L, Grugni R, Bonfanti G, Emir B, Whalen E, Watt S, Brodsky M, Parsons B
Pragmatic and Observational Research 2019, 10:67-76
Published Date: 31 October 2019
The relationship between the reporting of euphoria events and early treatment responses to pregabalin: an exploratory post-hoc analysis
Parsons B, Freynhagen R, Schug S, Whalen E, Ortiz M, Bhadra Brown P, Knapp L
Journal of Pain Research 2019, 12:2577-2587
Published Date: 22 August 2019
Effectiveness of pregabalin for treatment of chronic cervical radiculopathy with upper limb radiating pain: an 8-week, multicenter prospective observational study in Japanese primary care settings
Taguchi T, Nozawa K, Parsons B, Yoshiyama T, Ebata N, Igarashi A, Fujii K
Journal of Pain Research 2019, 12:1411-1424
Published Date: 3 May 2019
The efficacy of pregabalin for the treatment of neuropathic pain in Japanese subjects with moderate or severe baseline pain
Parsons B, Fujii K, Nozawa K, Yoshiyama T, Ortiz M, Whalen E
Journal of Pain Research 2019, 12:1061-1068
Published Date: 22 March 2019
Epidemiology of physician-diagnosed neuropathic pain in Brazil
Udall M, Kudel I, Cappelleri JC, Sadosky A, King-Concialdi K, Parsons B, Hlavacek P, Hopps M, Salomon PA, DiBonventura MD, Clark P, Santos Garcia JB
Journal of Pain Research 2019, 12:243-253
Published Date: 7 January 2019
Characteristics of patients with neuropathic pain syndromes screened by the painDETECT questionnaire and diagnosed by physician exam
Kudel I, Hopps M, Cappelleri JC, Sadosky A, King-Concialdi K, Liebert R, Parsons B, Hlavacek P, Alexander AH, DiBonventura M, Markman JD, Farrar JT, Stacey BR
Journal of Pain Research 2019, 12:255-268
Published Date: 7 January 2019
Comparison of the efficacy and safety of pregabalin for postherpetic neuralgia in Chinese and international patients
Parsons B, Pan X, Xie L, Chen YX, Ortiz M, Whalen E
Journal of Pain Research 2018, 11:1699-1708
Published Date: 3 September 2018
The prevalence of probable neuropathic pain in the US: results from a multimodal general-population health survey
DiBonaventura MD, Sadosky A, Concialdi K, Hopps M, Kudel I, Parsons B, Cappelleri JC, Hlavacek P, Alexander AH, Stacey BR, Markman JD, Farrar JT
Journal of Pain Research 2017, 10:2525-2538
Published Date: 1 November 2017
The safety profile of parecoxib for the treatment of postoperative pain: a pooled analysis of 28 randomized, double-blind, placebo-controlled clinical trials and a review of over 10 years of postauthorization data
Schug SA, Parsons B, Li C, Xia F
Journal of Pain Research 2017, 10:2451-2459
Published Date: 10 October 2017
Parecoxib relieves pain and has an opioid-sparing effect following major gastrointestinal surgery
Essex MN, Xu H, Parsons B, Xie L, Li C
International Journal of General Medicine 2017, 10:319-327
Published Date: 28 September 2017
Neuropathic pain responds better to increased doses of pregabalin: an in-depth analysis of flexible-dose clinical trials
Serpell M, Latymer M, Almas M, Ortiz M, Parsons B, Prieto R
Journal of Pain Research 2017, 10:1769-1776
Published Date: 26 July 2017
Effects of parecoxib on postoperative pain and opioid-related symptoms following gynecologic surgery
Parsons B, Zhu Q, Xie L, Li C, Cheung R
Journal of Pain Research 2016, 9:1101-1107
Published Date: 25 November 2016
Improvement in pain severity category in clinical trials of pregabalin
Parsons B, Argoff CE, Clair A, Emir B
Journal of Pain Research 2016, 9:779-785
Published Date: 7 October 2016
Pain relief and functional improvement in patients with neuropathic pain associated with spinal cord injury: an exploratory analysis of pregabalin clinical trials
Sadosky A, Parsons B, Emir B, Nieshoff EC
Journal of Pain Research 2016, 9:405-416
Published Date: 15 June 2016
Effectiveness of pregabalin for the treatment of chronic low back pain with accompanying lower limb pain (neuropathic component): a non-interventional study in Japan
Taguchi T, Igarashi A, Watt S, Parsons B, Sadosky A, Nozawa K, Hayakawa K, Yoshiyama T, Ebata N, Fujii K
Journal of Pain Research 2015, 8:487-497
Published Date: 5 August 2015
Temporal analysis of pain responders and common adverse events: when do these first appear following treatment with pregabalin
Parsons B, Emir B, Clair A
Journal of Pain Research 2015, 8:303-309
Published Date: 29 June 2015
Predictors of placebo response in peripheral neuropathic pain: insights from pregabalin clinical trials
Freeman R, Emir B, Parsons B
Journal of Pain Research 2015, 8:257-268
Published Date: 1 June 2015
Pregabalin for the treatment of postoperative pain: results from three controlled trials using different surgical models
Singla NK, Chelly JE, Lionberger DR, Gimbel J, Sanin L, Sporn J, Yang R, Cheung R, Knapp L, Parsons B
Journal of Pain Research 2015, 8:9-20
Published Date: 23 December 2014
Pain severity and the economic burden of neuropathic pain in the United States: BEAT Neuropathic Pain Observational Study
Schaefer C, Sadosky A, Mann R, Daniel S, Parsons B, Tuchman M, Anschel A, Stacey BR, Nalamachu S, Nieshoff E
ClinicoEconomics and Outcomes Research 2014, 6:483-496
Published Date: 29 October 2014
Impact of potential pregabalin or duloxetine drug–drug interactions on health care costs and utilization among Medicare members with fibromyalgia
Ellis JJ, Sadosky AB, Ten Eyck LL, Cappelleri JC, Brown CR, Suehs BT, Parsons B
ClinicoEconomics and Outcomes Research 2014, 6:389-399
Published Date: 14 October 2014
Economic and humanistic burden of post-trauma and post-surgical neuropathic pain among adults in the United States
Parsons B, Schaefer C, Mann R, Sadosky A, Daniel S, Nalamachu S, Stacey BR, Nieshoff EC, Tuchman M, Anschel A
Journal of Pain Research 2013, 6:459-469
Published Date: 17 June 2013
Burden of illness associated with painful diabetic peripheral neuropathy among adults seeking treatment in the US: results from a retrospective chart review and cross-sectional survey
Sadosky A, Schaefer C, Mann R, Bergstrom F, Baik R, Parsons B, Nalamachu S, Nieshoff E, Stacey BR, Anschel A, Tuchman M
Diabetes, Metabolic Syndrome and Obesity 2013, 6:79-92
Published Date: 8 February 2013
Double-blind comparison of ziprasidone and risperidone in the treatment of Chinese patients with acute exacerbation of schizophrenia
Hongyan Zhang, Huafang Li, Liang Shu, et al
Neuropsychiatric Disease and Treatment 2011, 7:77-85
Published Date: 4 March 2011